Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9393 Towne Centre Drive
Suite 200
San Diego, CA 92121Phone+1 858-332-3428
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1993 - 1996
- Universidade de Sao Paulo Faculty of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 1996 - 2026
- TX State Medical License 2002 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma Start of enrollment: 2018 Sep 11
- Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 Start of enrollment: 2018 Dec 26
Publications & Presentations
PubMed
- 1725 citationsOverall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell CarcinomaRobert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski
Journal of Clinical Oncology. 2009-08-01 - 29 citationsAntitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study.Marc Oliva, Douglas B. Chepeha, Daniel Vilarim Araujo, J. Javier Díaz-Mejía, Peter Olson
Journal for Immunotherapy of Cancer. 2021-10-01 - 1008 citationsPD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroRichard S. Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David Cohen
Breast Cancer Research. 2009-10-29
Press Mentions
- Chutes & Ladders—Warp Speed's Slaoui Sells $12M in Moderna StockMay 22nd, 2020
- Stopping and Starting Cancer Cell Cycle Weakens and Defeats Multiple MyelomaJune 21st, 2012
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: